what are glp-1 drugs made from Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response America's Poison Centers - GLP-1
Description
Liraglutide (3.0 mg, daily subcutaneous injection, n=22) or semaglutide (1.0 mg, weekly subcutaneous injection, n=18) was started 74.5 (51.0, 108.3) months after surgery following a weight regain of 14.7 (10.3, 19.6)%
Recent Findings Retatrutide is the first triple agonist (acting on GLP-1/GIP/glucagon receptors) with published phase 2 data in people with obesity as well as in people with T2D
Ozempic (semaglutide) is a medication used to manage type 2 diabetes
#glp1 #diabetes #medication #T2DM | 28 comments on LinkedIn
